Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.37 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.37 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.37 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.37 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.37 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.37 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.37 |
| ▸ | PNMT | P11086 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15946908 | 0.86 | TAAR1 (0.32) | TAAR1SLC6A2MAOASLC6A4SLC6A3 | |
| SCHEMBL9453231 | 0.83 | TAAR1 (0.44) | TAAR1SLC6A2MAOASLC6A4SLC6A3 | |
| SCHEMBL14822593 | 0.79 | TAAR1 (0.31) | TAAR1SLC6A2SLC6A3HTR2AHTR2B | |
| SCHEMBL11763961 | 0.79 | HTR2A (0.42) | SIGMAR1CYP2A6GRIN2DGRIN2AGRIN2B | |
| SCHEMBL14810256 | 0.73 | TAAR1 (0.35) | TAAR1SLC6A2MAOASLC6A4SLC6A3 | |
| SCHEMBL4449680 | 0.72 | MEN1 (0.36) | TAAR1SLC6A2MAOASLC6A4SLC6A3 | |
| SCHEMBL11760566 | 0.71 | HTR2A (0.37) | CYP2A6GRIN2DGRIN2AGRIN2BGRIN2C | |
| SCHEMBL3630782 | 0.70 | GABRA1 (0.34) | TAAR1SLC6A2MAOASLC6A4SLC6A3 | |
| SCHEMBL11764978 | 0.70 | CYP1A2 (0.36) | SIGMAR1CYP2D6KMT2A | |
| SCHEMBL1465458 | 0.70 | KCNH2 (0.38) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113896607-B | Olefin oligomerization process using a catalyst comprising a chromium complex having a phosphacycle-containing ligand | 陶氏环球技术有限责任公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20220176363-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-06-09 | — | — | US | disclosed |
| CN-107548385-B | Olefin oligomerization process using catalyst comprising chromium complex with phosphacycle-containing ligand | 陶氏环球技术有限责任公司 | 2022-01-21 | — | — | CN | disclosed |
| US-20210129125-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-05-06 | — | — | US | disclosed |
| US-10981156-B2 | Chromium complex and catalyst therefrom | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-04-20 | — | — | US | disclosed |
| US-10919031-B2 | Process for oligomerization | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-02-16 | — | — | US | disclosed |
| US-20200338542-A1 | PROCESS FOR OLIGOMERIZATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-10-29 | — | — | US | disclosed |
| US-10702861-B2 | Process for oligomerization | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-07-07 | — | — | US | disclosed |
| EP-3653299-A1 | CHROMIUM COMPLEX WITH A PHOSPHACYCLE-CONTAINING LIGAND AND OLEFIN OLIGOMERISATION CATALYST THEREFROM | Dow Global Technologies LLC (US) | 2020-05-20 | — | — | EP | disclosed |
| EP-3653300-A1 | OLEFIN OLIGOMERIZATION PROCESS WITH A CATALYST COMPRISING A CHROMIUM COMPLEX WITH A PHOSPHACYCLE-CONTAINING LIGAND | Dow Global Technologies LLC (US) | 2020-05-20 | — | — | EP | disclosed |
| CN-101730656-B | Method for the production of hydrogen from ammonia borane | 卡娜塔化学技术股份有限公司 | 2017-05-03 | — | — | CN | disclosed |
| US-20140228573-A1 | Zirconium Containing Hydrosilylation Catalysts and Compositions Containing the Catalysts | DOW CORNING CORPORATION (US) | 2014-08-14 | — | — | US | disclosed |
| US-20140228573-A1 | Zirconium Containing Hydrosilylation Catalysts and Compositions Containing the Catalysts | DOW CORNING CORPORATION (US) | 2014-08-14 | — | — | US | disclosed |
| US-8518368-B2 | Method for the production of hydrogen from ammonia borane | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2013-08-27 | — | — | US | disclosed |
| US-8518368-B2 | Method for the production of hydrogen from ammonia borane | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2013-08-27 | — | — | US | disclosed |
| WO-2013043799-A1 | ZIRCONIUM CONTAINING HYDROSILYLATION CATALYSTS AND COMPOSITIONS CONTAINING THE CATALYSTS | DOW CORNING CORPORATION (US) | 2013-03-28 | — | — | WO | disclosed |
| US-20110070152-A1 | METHOD FOR THE PRODUCTION OF HYDROGEN FROM AMMONIA BORANE | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2011-03-24 | — | — | US | disclosed |
| US-20110070152-A1 | METHOD FOR THE PRODUCTION OF HYDROGEN FROM AMMONIA BORANE | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2011-03-24 | — | — | US | disclosed |
| EP-2158154-A1 | METHOD FOR THE PRODUCTION OF HYDROGEN FROM AMMONIA BORANE | Kanata Chemical Technologies Inc. (CA) | 2010-03-03 | — | — | EP | disclosed |
| WO-2008141439-A1 | METHOD FOR THE PRODUCTION OF HYDROGEN FROM AMMONIA BORANE | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2008-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210129125-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | TAAR1 1180/4885SLC6A2 4876/4885MAOA 954/4885 |
| US-20200338542-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | TAAR1 1180/4885SLC6A2 4876/4885MAOA 954/4885 |
| US-10919031-B2 | Process for oligomerization | OXER1, NOD1, LIG1 | TAAR1 1180/4885SLC6A2 4876/4885MAOA 954/4885 |
| US-10981156-B2 | Chromium complex and catalyst therefrom | OXER1, LIG1, PICALM | TAAR1 2024/4885SLC6A2 4864/4885MAOA 1915/4885 |
| US-20220176363-A1 | PROCESS FOR OLIGOMERIZATION | OXER1, NOD1, LIG1 | TAAR1 1180/4885SLC6A2 4876/4885MAOA 954/4885 |
| US-20140228573-A1 | Zirconium Containing Hydrosilylation Catalysts and Compositions Containing the Catalysts | ALG8, ZRANB2, ZKSCAN2 | TAAR1 2863/4885SLC6A2 4792/4885MAOA 3510/4885 |
| US-10702861-B2 | Process for oligomerization | OXER1, NOD1, LIG1 | TAAR1 1180/4885SLC6A2 4876/4885MAOA 954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.